| 2025-12-02 |
复牌提示：
2025-12-02 10:07:16 停牌，复牌日期 2025-12-02 10:12:16
|
| 2025-10-27 |
股东大会：
将于2025-11-18召开股东大会
会议内容 ▼▲
- 1.To consider and vote upon a proposal to approve the Business Combination described in this proxy statement/prospectus, including (a) adopting the Transaction Agreement, a copy of which is attached to the accompanying proxy statement/prospectus as Annex A, which, among other things, provides for the Rorschach Merger and the Company Merger resulting in each of Sonnet and Rorschach surviving as a direct, wholly-owned subsidiary of Pubco, and (b) approving the other transactions contemplated by the Transaction Agreement and related agreements described in this proxy statement/prospectus;
2.To consider and vote upon, on a non-binding advisory basis, the following proposals to approve the material differences between the Sonnet Charter and the Pubco Charter, attached hereto as Annex B to this proxy statement/prospectus, respectively, to be in effect upon consummation of the Business Combination: (A) Authorized Capital Stock — approve authorized capital stock of Pubco of 2,000,000,000 shares of Pubco Common Stock, par value $0.01 per share, and 100,000,000 shares of preferred stock; (B) Removal of Directors — approve a provision that, except for any Series Directors, any individual director or the entire Pubco Board of Directors may be removed from office at any time, but only for cause, and only by the affirmative vote of holders of a majority of the voting power of all then outstanding shares of capital stock of Pubco entitled to vote generally in the election of directors, voting together as a single class; (C) Stockholder Action by Written Consent — to approve a provision that, except as may be otherwise provided for or fixed pursuant to Pubco Charter (including any preferred stock designation) relating to the rights, if any, of the holders of any outstanding series of Preferred Stock, any action required or permitted to be taken by the stockholders of Pubco must be effected at a duly called annual or special meeting of the stockholders of Pubco (and may not be taken by consent of the stockholders in lieu of a meeting); (D) Special Meetings of Stockholders — approve a provision that, subject to the rights, if any, of the holders of any series of Preferred Stock as provided or fixed by or pursuant to the provisions of Pubco Charter (including any preferred stock designation), and to the requirements of applicable law, special meetings of the stockholders of Pubco may be called for any purpose or purposes, at any time, only by or at the direction of Pubco Board of Directors pursuant to a resolution adopted by a majority of Pubco Board of Directors, the Chairperson of Pubco Board of Directors, the Chief Executive Officer or President and will not be called by any other person or persons; (E) Amendment of the Charter — approve a provision that amendment of Pubco Charter generally requires the approval of Pubco Board of Directors and a majority of the combined voting power of the then-outstanding shares of voting stock, voting together as a single class, with the exception of certain provisions that would require the affirmative vote of at least 66 2/3% of the total voting power of all the then outstanding shares of stock of the company entitled to vote thereon, voting as a single class.
3.To consider and vote on a proposal to approve, for purposes of complying with applicable listing rules of the Nasdaq Capital Market (“Nasdaq”), the issuance of shares of Company Common Stock issuable (i) upon conversion of the 7,500 shares of the Company’s Series 5 Convertible Preferred Stock (the “Series 5 Preferred Stock”) issued in the Company’s private placement in July 2025, (ii) upon exercise of warrants to purchase up to 12,000,000 shares of Company Common Stock (the “PIPE Warrants”), issued in the Company’s private placement in July 2025, (iii) upon exercise of warrants to purchase up to 865,052 shares of Company Common Stock issued in the Company’s bridge financing in June 2025 and (iv) under the Subscription Agreements, pursuant to which 243,787,992 shares of Company Common Stock will be issued immediately prior to the Closing (all share numbers are prior to giving effect to the five-for-one exchange ratio in the Transaction Agreement);
4.To consider and vote on a proposal to approve and adopt the 2025 Equity Incentive Plan established to be effective after the Closing;
5.To approve an amendment to our Certificate of Incorporation, as amended to date (the “Sonnet Charter”) to increase the authorized shares of Company Common Stock from 125,000,000 to 500,000,000;
6.To consider and vote upon a proposal to adjourn the special meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of one or more proposals at the special meeting.
|
| 2025-10-27 |
详情>>
股本变动：
变动后总股本707.79万股
|
| 2025-08-26 |
股东大会：
将于2025-09-26召开股东大会
会议内容 ▼▲
- 1.To elect five directors to our Board of Directors (the “Board”) to hold office for the following year until their successors are elected;
2.To approve, on an advisory basis, the executive compensation of our named executive officers (the “Named Executive Officers”) as described in this proxy statement;
3.To vote, on an advisory basis, on how frequently we should seek approval from our stockholders, on an advisory basis, of the compensation paid to our Named Executive Officers;
4.To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending September 30, 2025;
5.To consider any other matters that may properly come before the Annual Meeting.
|
| 2025-08-13 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-3.16美元,归母净利润-1042.76万美元,同比去年增长-142.02%
|
| 2025-07-11 |
详情>>
内部人交易：
MCANDREW STEPHEN J等共交易9笔
|
| 2025-05-13 |
详情>>
业绩披露：
2025年中报每股收益-2.25美元,归母净利润-665.18万美元,同比去年增长-728.29%
|
| 2025-02-13 |
详情>>
业绩披露：
2025年一季报每股收益-1.56美元,归母净利润-316.07万美元,同比去年增长-170.49%
|
| 2024-12-17 |
详情>>
业绩披露：
2024年年报每股收益-11.35美元,归母净利润-743.72万美元,同比去年增长60.51%
|
| 2024-09-30 |
详情>>
拆分方案：
每8.0000合并分成1.0000股
|
| 2024-08-19 |
股东大会：
将于2024-09-12召开股东大会
会议内容 ▼▲
- 1.To elect six directors to our Board of Directors (the “Board”) to hold office for the following year until their successors are elected;
2.To approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of more than 20% of our issued and outstanding common stock pursuant to our ChEF Purchase Agreement with Chardan Capital Markets LLC;
3.To approve an amendment to our Certificate of Incorporation, as amended, to effect a reverse stock split of our issued and outstanding shares of common stock, at a specific ratio, ranging from one-for-two (1:2) to one-for-twelve (1:12), at any time prior to the one-year anniversary date of the Annual Meeting, with the exact ratio to be determined by the Board;
4.To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending September 30, 2024;
5.To consider any other matters that may properly come before the Annual Meeting.
|
| 2024-08-14 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.96美元,归母净利润-430.86万美元,同比去年增长71.57%
|
| 2024-05-14 |
详情>>
业绩披露：
2024年中报每股收益-0.19美元,归母净利润-80.31万美元,同比去年增长92.84%
|
| 2024-02-14 |
详情>>
业绩披露：
2024年一季报每股收益-0.31美元,归母净利润-116.85万美元,同比去年增长78.92%
|
| 2023-12-14 |
详情>>
业绩披露：
2023年年报每股收益-18.14美元,归母净利润-1883.27万美元,同比去年增长36.64%
|
| 2023-09-01 |
详情>>
拆分方案：
每22.0000合并分成1.0000股
|
| 2023-08-14 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.86美元,归母净利润-1515.6万美元,同比去年增长31.99%
|
| 2023-08-07 |
股东大会：
将于2023-08-31召开股东大会
会议内容 ▼▲
- 1.To elect six directors to the Company’s Board of Directors (the “Board) to hold office for the following year until their successors are elected;
2.To approve an amendment to our Certificate of Incorporation, as amended (the “Charter”), to effect a reverse stock split of our issued and outstanding shares of Common Stock, at a specific ratio, ranging from two-for-one (2:1) to thirty five-for-one (35:1), at any time prior to the one-year anniversary date of the annual meeting, with the exact ratio to be determined by the Board (the “Reverse Split”);
3.To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending September 30, 2023;
4.To consider any other matters that may properly come before the Annual Meeting.
|
| 2023-05-10 |
详情>>
业绩披露：
2023年中报每股收益-0.96美元,归母净利润-1120.92万美元,同比去年增长22.21%
|
| 2022-09-19 |
详情>>
拆分方案：
每14.0000合并分成1.0000股
|
| 2022-08-25 |
股东大会：
将于2022-09-15召开股东大会
会议内容 ▼▲
- 1.Adoption and approval of an amendment to our certificate of incorporation, as amended (the “Charter”), to effect a reverse stock split of our issued and outstanding shares of Common Stock, par value $0.0001 per share (the “Common Stock”) and shares of Common Stock held by us in treasury, at a specific ratio, ranging from one-for-two (1:2) to one-for-forty (1:40), at any time prior to the one-year anniversary date of the Special Meeting, with the exact ratio to be determined by the Board without further approval or authorization of our stockholders (the “Reverse Split”);
2.Approval of the adjournment of the Special Meeting to the extent there are insufficient proxies at the Special Meeting to approve the Reverse Split proposal.
|
| 2022-04-12 |
股东大会：
将于2022-06-02召开股东大会
会议内容 ▼▲
- 1.To elect five directors to the Company’s Board of Directors to hold office for the following year until their successors are elected;
2.To approve an amendment to our Certificate of Incorporation, as amended (the “Charter”), to effect a reverse stock split of our issued and outstanding shares of Common Stock, at a specific ratio, ranging from two-for-one (2:1) to twenty-for-one (20:1), at any time prior to the one-year anniversary date of the annual meeting, with the exact ratio to be determined by the Board (the “Reverse Split”);
3.To approve an amendment to our Charter to increase our authorized shares of Common Stock from 125,000,000 to 250,000,000 (the “Authorized Share Increase”);
4.To approve, on an advisory basis, the executive compensation of the Company’s named executive officers as described in this proxy statement;
5.To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending September 30, 2022;
6.To consider any other matters that may properly come before the Annual Meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-05-25 |
股东大会：
将于2021-06-24召开股东大会
会议内容 ▼▲
- 1.To elect five directors to the Company’s Board of Directors to hold office for the following year until their successors are elected;
2.To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending September 30, 2021;
3.To consider any other matters that may properly come before the Annual Meeting.
|
| 2020-04-02 |
详情>>
拆分方案：
每26.0000合并分成1.0000股
|
| 2019-11-19 |
股东大会：
将于2019-12-20召开股东大会
会议内容 ▼▲
- 1.To elect Michael D. Pruitt, Neil C. Kiefer, Keith J. Johnson, J. Eric Wagoner, Frederick L. Glick, and Russell J. Page to serve a one-year term until their respective successors are duly elected and qualified or until their death, resignation, removal or disqualification;
2.Whether to approve, on an advisory basis, the compensation of our Named Executive Officers (as defined in the Proxy Statement), (the say-on-pay proposal);
3.To vote, on an advisory basis, on how frequently we should seek approval from our stockholders, on an advisory basis, of the compensation paid to our Named Executive Officers, (the say-on-frequency proposal);
4.To ratify the appointment of Cherry Bekaert LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2019;
5.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2018-07-13 |
股东大会：
将于2018-08-23召开股东大会
会议内容 ▼▲
- 1.To elect Michael D. Pruitt, Neil C. Kiefer, Keith J. Johnson, J. Eric Wagoner, Larry S. Spitcaufsky, David P. Osborn, and Russell J. Page to serve a one-year term until their respective successors are duly elected and qualified or until their death, resignation, removal or disqualification.
2.To approve, on an advisory basis, the compensation of our Named Executive Officers (as defined in the Proxy Statement).
3.To ratify the appointment of Cherry Bekaert LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2018.
4.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2017-05-18 |
详情>>
拆分方案：
每10.0000合并分成1.0000股
|
| 2017-04-19 |
股东大会：
将于2017-05-15召开股东大会
会议内容 ▼▲
- 1.To elect Michael D. Pruitt, Gregory E. Kraut, Neil C. Kiefer, Keith J. Johnson, and Russell J. Page to serve a one-year term until their respective successors are duly elected and qualified or until their death, resignation, removal or disqualification.
2.To authorize the Company’s Board of Directors, in its sole discretion, to amend the Company’s certificate of incorporation to effect a reverse stock split between one-for two (1:2) and one-for-ten (1:10) by June 30, 2017 (the “Reverse Stock Split”).
3.To approve an amendment to the Company bylaws to authorize the Board of Directors to set the maximum size of the board between five (5) and nine (9) seats, from time to time.
4.To approve, on an advisory basis, the compensation of our Named Executive Officers (as defined in the Proxy Statement).
5.To ratify the appointment of Cherry Bekaert LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2017.
6.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2016-08-01 |
股东大会：
将于2016-09-15召开股东大会
会议内容 ▼▲
- 1.To elect Michael D. Pruitt, Michael Carroll, Keith Johnson, Paul I. Moskowitz and Russell “Rusty” Page to serve a one-year term until their respective successors are duly elected and qualified or until their death, resignation, removal or disqualification.
2.To approve, on an advisory basis, the compensation of our Named Executive Officers (as defined in the Proxy Statement).
3.To ratify the appointment of Cherry Bekaert LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2016.
4.To transact such other business as may properly come before the annual meeting or any adjournment or postponement thereof.
|